Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle
Open Access

Livedo Reticularis After COVID-19 Vaccination

Taro Horino, Satoshi Inotani, Kimiko Nakajima and Yoshio Terada
The Journal of Rheumatology October 2022, jrheum.220584; DOI: https://doi.org/10.3899/jrheum.220584
Taro Horino
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Taro Horino
Satoshi Inotani
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimiko Nakajima
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshio Terada
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Livedo reticularis occurs when there is increased visibility of the venous plexus, often caused by reduced arterial inflow or venodilation.1 Although livedo reticularis has been reported in patients with COVID-19,2,3 it has also been reported following COVID-19 vaccination.4

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 50, Issue 1
1 Jan 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Livedo Reticularis After COVID-19 Vaccination
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Livedo Reticularis After COVID-19 Vaccination
Taro Horino, Satoshi Inotani, Kimiko Nakajima, Yoshio Terada
The Journal of Rheumatology Oct 2022, jrheum.220584; DOI: 10.3899/jrheum.220584

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Livedo Reticularis After COVID-19 Vaccination
Taro Horino, Satoshi Inotani, Kimiko Nakajima, Yoshio Terada
The Journal of Rheumatology Oct 2022, jrheum.220584; DOI: 10.3899/jrheum.220584
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
  • Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases
  • The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire